Investegate |Yaqrit Discovery Ltd Announcements | Yaqrit Discovery Ltd: Preliminary results from Carbalive and Dialive trials signal potential for new therapies to treat decompensated cirrhosis and reverse liver failure
Yaqrit Discovery Ltd Preliminary results from Carbalive and Dialive trials signal potential for new therapies to treat decompensated cirrhosis and reverse liver failure Preliminary results from Carbalive and Dialive trials signal potential for new therapies to treat decompensated cirrhosis and reverse liver failure Preliminary results from Carbalive and Dialive trials signal potential for new therapies to treat decompensated cirrhosis and reverse liver failure Orally-administered, non-absorbable engineered carbon, Carbalive ™, was safe, tolerable and showed trends in improvements in...
Source: investegate.co.uk